Genomics

MVIS Launches the MVIS Global Future Healthcare ESG Index

Designed to measure the performance of the genomic health care and electronic healthcare companies

MV Index Solutions GmbH (MVIS®) today announced the launch of the MVIS Global Future Healthcare ESG Index (ticker: MVFHC).

The MVIS Global Future Healthcare ESG Index (ticker: MVFHC) is a global index that mainly tracks the performance of companies that are involved in the genomic health care and electronic healthcare industries. The index includes companies that generate at least 50% of their revenue from healthcare therapies, technology platforms, laboratory equipment or services, e-Commerce pharmacies, software for the management of medical practices, patient records and online medical consultations and outpatient medical IoT devices. In addition, the index comprises the companies that meet certain ESG standards related to the sustainability and safety of the food and agriculture.

“We are excited to announce the launch of our global future healthcare ESG index today. This ESG-screened index provides investors with an investable benchmark covering companies leading the way in the fast-growing field of personalized and precision health care. The corona virus pandemic accelerated consumer adoption of e-healthcare platforms and reinvigorated the genomics-based health care therapies industry. This index allows investors to express a long-term view on the growth of these trends,” said Josh Kaplan, Global Head of Research & Investment Strategy at MV Index Solutions.

The MVIS Global Future Healthcare ESG Index (ticker: MVFHC) is weighted by free float market capitalisation and is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components. Detailed information about the index, including methodology details and index data, is available on the MV Index Solutions website.

Key Index Features
MVIS Global Future Healthcare ESG Index (ticker: MVFHC)
Number of Components: 63
Base Date: 31 December 2020
Base Value: 1000

Note to Editors:
About MV Index Solutions – www.mvis-indices.com
MV Index Solutions (MVIS®) develops, monitors and licenses the MVIS Indices and BlueStar Indexes, a selection of focused, investable and diversified benchmark indices. The indices are especially designed to underlie financial products. MVIS Indices cover several asset classes, including equity, fixed income markets and digital assets and are licensed to serve as underlying indices for financial products. Approximately USD 33.12 billion in assets under management (as of 6 December 2021) are currently invested in financial products based on MVIS/BlueStar Indices. MVIS is a VanEck company.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.

Related posts

Rady Children’s Institute for Genomic Medicine & PlumCare RWE Partner

PR Newswire

Truwl Releases Free Benchmarking Tool for Genomics

PR Newswire

Gene Therapy Co. GenSight Biologics to Host a Webinar

Business Wire